Precision Optics Corporation (NASDAQ: POCI) appointed Peter Thier as Senior Vice President of Sales and Marketing on August 18, 2026. Thier will lead the company's sales and marketing strategy, leveraging his background in medical technology and advanced product development.

The appointment aims to support Precision Optics' growth phase by strengthening its commercial pipeline and customer relationships in the healthcare and defense/aerospace industries.

Executive Background

Thier joins from Team Consulting, where he most recently served as Senior Vice President of Advanced MedTech and Business Development. In that role, he drove growth across advanced medical technology markets and developed strategic relationships with leading healthcare organizations.

He holds a Bachelor of Science degree in mechanical engineering from Worcester Polytechnic Institute. His career spans more than 30 years in sales, business development, strategy, and commercial leadership across the medical technology, life sciences, and advanced product development sectors.

Strategic Rationale

Dr. Joe Forkey, President and Chief Executive Officer of Precision Optics, stated that Thier’s experience in selling engineering services leading to manufacturing aligns directly with the company’s business model. Forkey noted that Thier has a proven ability to build commercial organizations and convert highly technical capabilities into large, long-term development and production programs.

Thier highlighted Precision Optics' differentiated platform at the intersection of advanced optics, imaging, engineering, and manufacturing. He noted that the company’s ability to work with customers from initial concept through scaled production creates a competitive advantage as customers seek smaller, higher-performance optical solutions.

Compensation Structure

In connection with his appointment, the Compensation Committee and Board approved a grant of an inducement stock option to purchase 50,000 shares of common stock. The grant was made pursuant to Nasdaq Rule 5635(c)(4).

The options vest in three equal annual installments on the first, second, and third anniversaries of his start date, subject to continued service. The exercise price equals the closing price of the company’s common stock on Nasdaq Capital Market on August 18, 2026.

Precision Optics Corporation (NASDAQ: POCI) will participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on Tuesday, August 18, 2026. The Littleton-based optics manufacturer scheduled a webcast presentation for 2:30 p.m. ET to engage with investors and analysts.

The virtual event offers a platform for the company to discuss its business outlook and operational strategy. Precision Optics designs and manufactures advanced optical instruments for medical and defense/aerospace sectors.

Event Details

The webcast is accessible through the summit homepage or a dedicated link for Precision Optics. A replay of the presentation will be available via the same channels following the live session.

Business Overview

Founded in 1982, Precision Optics operates as a vertically integrated optics company. It leverages proprietary micro-optics, 3D imaging, and digital imaging technologies for healthcare and defense/aerospace industries. The firm provides services ranging from new product concepts to mass manufacture.

In healthcare, the company supports next-generation medical device firms meeting demands for minimally invasive surgery and surgical robotic systems. Its Ross Optical division handles high-volume worldwide sourcing, inspecting, and production resources. In defense and aerospace, Precision Optics applies technical proficiency in micro-optics to meet stringent quality standards for size, weight, and power optimization.